Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff

Journal of the American Medical Directors Association

Volumn 14, Issue 12, 2013, Pages 895-900

  Lemay, Celeste A ^a   Mazor, Kathleen M ^a   Field, Terry S ^a   Donovan, Jennifer ^a,b   Kanaan, Abir ^a,b   Briesacher, Becky A ^a   Foy, Sarah ^a   Harrold, Leslie R ^a   Gurwitz, Jerry H ^a   Tjia, Jennifer ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Atypical antipsychotics; Evidenced based prescribing; Nursing homes

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ADMINISTRATIVE PERSONNEL; AGITATION; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DRUG EFFICACY; DRUG FATALITY; EXTRAPYRAMIDAL SYMPTOM; FALLING; FATIGUE; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH BELIEF; HEALTH CARE SURVEY; HUMAN; HYPOTENSION; JOB SATISFACTION; LEADERSHIP; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NURSING HOME; NURSING HOME PERSONNEL; PAIN; PRACTICAL NURSE; QUESTIONNAIRE; REGISTERED NURSE; RESIDENT; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; STAFF TRAINING; TELEPHONE INTERVIEW; UNITED STATES; URINARY TRACT DISEASE; WEIGHT GAIN; XEROSTOMIA;

ATYPICAL ANTIPSYCHOTICS; EVIDENCED-BASED PRESCRIBING; NURSING HOMES;

ADMINISTRATIVE PERSONNEL; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; CONNECTICUT; DEMENTIA; EVIDENCE-BASED PRACTICE; HUMANS; MEDICAL STAFF; NEEDS ASSESSMENT; NURSING HOMES; NURSING STAFF; QUESTIONNAIRES;

EID: 84897078369     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.08.009     Document Type: Article

References (31)

1. Chen Y., Briesacher B.A., Field T.S., et al. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010, 170:89-95.
2. Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents 2011, Department of Health and Human Services, Office of the Inspector General, Department of Health and Human Services, Washington, DC.
3. Ballard C., Day S., Sharp S., et al. Neuropsychiatric symptoms in dementia: Importance and treatment considerations. Int Rev Psychiatry 2008, 20:396-404.
4. Gill S.S., Bronskill S.E., Normand S.-L.T., et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007, 146:775-786.
5. Jeste D.V., Blazer D., Casey D., et al. ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008, 33:957-970. Available at:, Accessed February 12, 2013. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2553721%26tool=pmcentrez%26rendertype=abstract.
6. Madhusoodanan S., Shah P., Brenner R., Gupta S. Pharmacological treatment of the psychosis of Alzheimer's disease: What is the best approach?. CNS Drugs 2007, 21:101-115.
7. Ray W.A., Chung C.P., Murray K.T., et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. NEng J Med 2009, 360:225-235.
8. Wang P.S., Schneeweiss S., Avorn J., et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. NEng J Med 2005, 353:2335-2341.
9. US Department of Health and Human Services, Food and Drug Administration, Public Health Advisory. Deaths with antipsychotics in elderly patients with behavioral disturbances. 2005. Available at: Accessed May 3, 2013. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171.htm.
10. Food and Drug Administration, Information for Healthcare Professionals. Conventional antipsychotics 2008, US Department of Health and Human Services, Available at:, Accessed May 3, 2013. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm.
11. Maher A.R., Maglione M., Bagley S., et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis. JAMA 2011, 306:1359-1369.
12. Maglione M, Maher AR, Hu J-H, etal. Off-Label Use of Atypical Antipsychotics: An Update. AHRQ Comparative Effectiveness Reviews. Rockville, MD;2011.
13. Hermes E.D.A., Sernyak M., Rosenheck R. Impact of a program encouraging the use of generic antipsychotics. Am J Manag Care 2012, 18:e307-e314.
14. Avorn J., Soumerai S.B., Everitt D.E., et al. Arandomized trial of a program to reduce the use of psychoactive drugs in nursing homes. NEng J Med 1992, 327:168-173.
15. Ray W.A., Taylor J.A., Meador K.G., et al. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med 1993, 153:713-721.
16. Mollot RJ, Butler D, Long Term Care Community Coalition. Federal requirements & regulatory provisions relevant to dementia care & the use of antipsychotic drugs. 2012. Available at: Accessed April 12,2013. http://www.theconsumervoice.org/sites/default/files/ltccc-antipsychotic-drugs-oversight-ftags-2012.pdf.
17. Briesacher B.A., Limcangco M.R., Simoni-Wastila L., et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005, 165:1280-1285.
18. Hughes C.M., Lapane K., Watson M.C., Davies H.T.O. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging 2007, 24:81-93.
19. Tjia J., Gurwitz J.H., Briesacher B.A. Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother 2012, 10:37-46.
20. Centers for Medicare & Medicaid Services. Nursing Home Compare. Available at: Accessed April 9,2011. http://www.medicare.gov/download/downloaddb.asp.
21. Nursing Home Survey on Patient Safety Culture. March 2012. Rockville (MD): Agency for Healthcare Research and Quality. Available at: Accessed May 3, 2013. http://www.ahrq.gov/qual/patientsafetyculture/nhsurvindex.htm.
22. Harris P.A., Taylor R., Thielke R., et al. Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. JBiomed Inform 2009, 42:377-381.
23. Agency for Healthcare Research and Quality. Off-label use of atypical antipsychotics drugs: A summary for clinicians and policy makers. 2007. Available at: Accessed May 3,2011. http://www.effectivehealthcare.ahrq.gov/.
24. Jones A.L., Dwyer L.L., Bercovitz A.R., Strahan G.W. The National Nursing Home Survey: 2004 overview. Vital Health Stat 13 2009, 167:1-155.
25. Cohen-Mansfield J., Jensen B., Resnick B., Norris M. Knowledge of and attitudes toward nonpharmacological interventions for treatment of behavior symptoms associated with dementia: a comparison of physicians, psychologists, and nurse practitioners. Gerontologist 2012, 52:34-45.
26. Fossey J., Ballard C., Juszczak E., et al. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ 2006, 332:756-761.
27. Shojania K.G., Grimshaw J.M. Evidence-based quality improvement: The state of the science. Health Aff (Millwood) 2005, 24:138-150.
28. Curry L., Porter M., Michalski M., Gruman C. Individualized care: Perceptions of certified nurse's aides. JGerontol Nurs 2000, 26:45-51. quiz 52-53.
29. Pennington K., Scott J., Magilvy K. The role of certified nursing assistants in nursing homes. JNurs Adm 2003, 33:578-584.
30. Sung H., Chang S., Tsai C. Working in long-term care settings for older people with dementia: nurses' aides. JClin Nurs 2005, 14:587-593.
31. Ramirez M., Teresi J., Holmes D. Demoralization and attitudes toward residents among certified nurse assistants in relation to job stressors and work resources: Cultural diversity in long term care. JCult Divers 2006, 13:119-125.